Antiangiogenic therapy for Hepatacellular carcinoma: Tumor suppressor Menin (MEN1) inhibits the progression of human hepatocellular carcinoma through suppression of the oncogenic HGF-c-Met pathway, 15/July/2014, 4.56 am

Antiangiogenic therapy for Hepatacellular carcinoma: Tumor suppressor Menin (MEN1) inhibits the progression of human hepatocellular carcinoma through suppression of the oncogenic HGF-c-Met pathway, 15/July/2014, 4.56 am

Antiangiogenic therapy for Hepatacellular carcinoma: Tumor suppressor Menin (MEN1) inhibits the progression of human hepatocellular carcinoma through suppression of the oncogenic HGF-c-Met pathway, 15/July/2014, 4.56 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan,  L., Antiangiogenic therapy for Hepatacellular carcinoma: Tumor suppressor Menin (MEN1) inhibits the progression of human hepatocellular carcinoma through suppression of the oncogenic HGF-c-Met pathway, 15/July/2014, 4.56 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing